These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6141490)

  • 1. [3H] dynorphin binding to guinea pig and rat brain.
    Young E; Walker JM; Houghten R; Akil H
    Life Sci; 1983; 33 Suppl 1():287-90. PubMed ID: 6141490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]dynorphin A binding and kappa selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain.
    Young EA; Walker JM; Lewis ME; Houghten RA; Woods JH; Akil H
    Eur J Pharmacol; 1986 Mar; 121(3):355-65. PubMed ID: 2870933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]-dynorphin A (1-9): binding characteristics and degradation profile in brain homogenates.
    Robson LE; Gillan MG; McKnight AT; Kosterlitz HW
    Life Sci; 1983; 33 Suppl 1():283-6. PubMed ID: 6319878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptor binding profile of [3H]dynorphin A-(1-8) in rat and guinea pig brain.
    Quirion R; Pilapil C
    Eur J Pharmacol; 1984 Apr; 99(4):361-3. PubMed ID: 6329791
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding of [3H]dynorphin A to apparent kappa opioid receptors in deep layers of guinea pig cerebral cortex.
    Lewis ME; Young EA; Houghten RA; Akil H; Watson SJ
    Eur J Pharmacol; 1984 Feb; 98(1):149-50. PubMed ID: 6143673
    [No Abstract]   [Full Text] [Related]  

  • 6. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
    Chavkin C; James IF; Goldstein A
    Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
    Devlin T; Shoemaker WJ
    J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL; Zarr GD; Brown SR; Cox BM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa-binding and degradation of [3H]dynorphin A (1-8) and [3H]dynorphin A (1-9) in suspensions of guinea pig brain membranes.
    Gillan MG; Robson LE; McKnight AT; Kosterlitz HW
    J Neurochem; 1985 Oct; 45(4):1034-42. PubMed ID: 2863329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]Dynorphin A binds selectively to guinea pig brain.
    Young EA; Walker JM; Houghten R; Akil H
    Eur J Pharmacol; 1983 Jul; 91(2-3):327-8. PubMed ID: 6137397
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.
    Corbett AD; Paterson SJ; McKnight AT; Magnan J; Kosterlitz HW
    Nature; 1982 Sep; 299(5878):79-81. PubMed ID: 6125893
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoradiographic visualization of kappa opioid receptors with labelled dynorphins in guinea pig brain.
    Slater P; Cross AJ; Hewitt L; Savage WJ
    J Recept Res; 1989; 9(2):171-80. PubMed ID: 2568485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster.
    McLean S; Rothman RB; Jacobson AE; Rice KC; Herkenham M
    J Comp Neurol; 1987 Jan; 255(4):497-510. PubMed ID: 2880880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin.
    James IF; Chavkin C; Goldstein A
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7570-4. PubMed ID: 6130527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu opioid receptor activation reduces inhibitory postsynaptic potentials in hippocampal CA3 pyramidal cells of rat and guinea pig.
    Caudle RM; Chavkin C
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1361-9. PubMed ID: 1969476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of amino-terminal sequence of beta-endorphin and dynorphin in the determination of opiate receptor type selectivity.
    Chang JK; Chang KJ
    Life Sci; 1983; 33 Suppl 1():267-9. PubMed ID: 6141489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific receptor for the opioid peptide dynorphin: structure--activity relationships.
    Chavkin C; Goldstein A
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6543-7. PubMed ID: 6118865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.
    Chang KJ; Blanchard SG; Cuatrecasas P
    Mol Pharmacol; 1984 Nov; 26(3):484-8. PubMed ID: 6149459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group.
    Koike K; Takayanagi I; Hirakura Y; Matsueda R
    Arch Int Pharmacodyn Ther; 1991; 313():33-46. PubMed ID: 1687773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.